Cold Agglutinin Disease Foundation
Clinical Trials for CAD Sponsored by Sanofi Genzyme
New Data from Ongoing APL-2 Phase 2 Study in Patients with Cold Agglutinin Disease and Warm Antibody Autoimmune Hemolytic Anemia at ASH
Clinical Trials Recruiting 2018
Clinical Trial Recruiting
Rituximab was found to be effective in treating patients with Non-Hodgkins Lymphoma, its main use, however, it is now also being used in the treatment of Cold Agglutinin Disease.
Copyright © 2020 Cold Agglutinin Disease Foundation - All Rights Reserved.
Powered by GoDaddy Website Builder